Oseltamivir Pharmacokinetics in Morbid Obesity.

Trial Profile

Oseltamivir Pharmacokinetics in Morbid Obesity.

Phase of Trial: Phase II

Latest Information Update: 15 May 2015

At a glance

  • Drugs Oseltamivir (Primary)
  • Indications Influenza virus infections
  • Focus Pharmacokinetics
  • Acronyms OPTIMO
  • Most Recent Events

    • 02 Aug 2011 Status changed from not yet recruiting to completed as reported by ClinicalTrials.gov.
    • 06 Nov 2009 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top